R. Kaiser

4.4k citations
119 papers · 3.5k · 1 hit paper · h-index 27

Impact in

  • Oncology top 2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Drug Transport and Resistance Mechanisms
    • Lung Cancer Treatments and Mutations
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

R. Kaiser

114 papers receiving 3.4k citations

R. Kaiser's Hit Papers

Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial 2014 · 718 citations
7180+4+8Years since publication200400600

Peers

R. Kaiser
Comparison fields: 5 of 121
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 1.3k
  • Hepatology 152
  • Cancer Research 260
  • Pharmacology 150
Replace Larry J. Schaaf with:
Larry J. Schaaf United States
Shiying Yu China
John Wong Hong Kong
Tetsuya Oguri Japan
M. Boisdron‐Celle France
Kuniaki Shirao Japan
Jan D’Haese Germany
Tom Boterberg Belgium
James P. O’Brien United States
Yan Huang China
R. Kaiser relative to Larry J. Schaaf United States Larry J. Schaaf's profile →
Citations per field
00.5×4.0×
Larry J. Schaaf · 1×
Citations per year

Countries citing papers authored by R. Kaiser

Since Specialization
Citations

This map shows the geographic impact of R. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Kaiser more than expected).

Fields of papers citing papers by R. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Kaiser. The network helps show where R. Kaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Kaiser Line = papers co-authored together R. Kaiser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Hit paper breakdown →
2014718
2 2014271
3 2002204
4 2009146
5 2003135
6 2008131
7 2011126
8 2010124
9 201086
10 200586
11 201081
12 201675
13 201170
14 201266
15 201365
16 201262
17 201450
18 201647
19 200243
20 200743

About R. Kaiser

R. Kaiser is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Hepatology, having authored 119 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Cancer Immunotherapy and Biomarkers (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Cancer Genomics and Diagnostics (8 papers), Lung Cancer Research Studies (8 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.3k citations), Hepatology (152 citations), Cancer Research (260 citations) and Pharmacology (150 citations). R. Kaiser has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Joachim von Pawel, Birgit Gaschler‐Markefski, Peter Stopfer, Jürgen Brockmöller, Martin Reck, José Barrueco, Maya Gottfried, Anders Mellemgaard, Silvia Novello and Igor Bondarenko. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Archives of Gynecology and Obstetrics, Lung Cancer and European Journal of Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact